Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa 2022-10-27 18:00
Antengene to Host Research and Development Day on November 15th and 17th, 2022 2022-10-27 11:07
SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES 2022-10-27 08:00
JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies 2022-10-27 07:53
Samsung Biologics Reports Third Quarter 2022 Financial Results 2022-10-27 07:35
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide 2022-10-27 06:44
Ascletis Announces U.S. IND Filing of Oral Antiviral ASC10 for Monkeypox Indication 2022-10-26 20:10
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting 2022-10-26 19:25
First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials 2022-10-26 17:00
Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022 2022-10-26 16:52
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round 2022-10-26 14:26
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
FDA Accepts NMP's Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis 2022-10-25 16:00
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval 2022-10-25 08:00
Transcenta to Participate in Four Upcoming Conferences 2022-10-24 21:00
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19 2022-10-24 17:59
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities 2022-10-24 08:30
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults 2022-10-22 03:25
Antengene Announces XPOVIO® Regulatory Approval in Taiwan for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma 2022-10-21 20:37
SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease 2022-10-21 20:36
1 115 116 117 118 119 385